Intensive Outpatient Versus Outpatient Treatment With Buprenorphine Among African Americans
NCT ID: NCT01096550
Last Updated: 2020-04-08
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
319 participants
INTERVENTIONAL
2010-03-31
2011-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Buprenorphine for Prisoners
NCT00574067
Contingency Management to Enhance Office-Based Buprenorphine Treatment
NCT04024059
Diversion to Treatment for Injection Drug Users Arrested for Possession of Heroin
NCT01723527
Buprenorphine Maintenance for Opioid-Addicted Persons in Jail and Post-Release
NCT00367302
Buprenorphine for Probationers and Parolees: Bridging the Gap Into Treatment
NCT03616236
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intensive Outpatient
Buprenorphine patients receiving 9 or more hours of outpatient counseling.
Intensive Outpatient
Buprenorphine patients receiving 9 or more hours of outpatient counseling.
Outpatient
Buprenorphine patients receiving between 2 and 8 hours of outpatient counseling.
Outpatient
Buprenorphine patients receiving 2 to 8 hours of outpatient counseling.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Outpatient
Buprenorphine patients receiving 2 to 8 hours of outpatient counseling.
Intensive Outpatient
Buprenorphine patients receiving 9 or more hours of outpatient counseling.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* new admissions to buprenorphine outpatient treatment
Exclusion Criteria
* acute medical or psychiatric illness
18 Years
85 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute on Drug Abuse (NIDA)
NIH
Friends Research Institute, Inc.
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Shannon G Mitchell, PhD
Role: PRINCIPAL_INVESTIGATOR
Friends Research Institute, Inc.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Friends Research Institute
Baltimore, Maryland, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.